Utilization and dose optimization of beta-blockers in chronic heart failure therapy: a mixed-methods study
The study highlights a significant therapeutic utilization gap in BBs, with only 10% of patients achieving optimal dosing. It recommends comprehensive training programs, strict adherence to guidelines, and improved medication accessibility.
Authors
- Getachew Yitayew Tarekegn (ORCID: https://orcid.org/0000-0002-8678-6723)
- Tilaye Arega Moges (ORCID: https://orcid.org/0000-0001-6813-8792)
- Abebech Tewabe Gelaye
- Samuel Berihun Dagnew (ORCID: https://orcid.org/0000-0002-8938-4551)
- Fisseha Nigussie Dagnew (ORCID: https://orcid.org/0009-0001-3309-9102)
- Gebremariam Wulie Geremew (ORCID: https://orcid.org/0009-0000-6691-8568)
- Sisay Sitotaw Anberbr
- Aragaw Dagnew Lakew
Institutions
- Debre Tabor University (ET)
- Bahir Dar University (ET)
- University of Gondar (ET)
Publication Details
- Journal
- BMC Cardiovascular Disorders
- Published
- 2025-06-08
- DOI
- https://doi.org/10.1186/s12872-025-04901-7
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Gondar